Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

RATIONALE: Regorafenib represents a treatment option in heavily pretreated patients affected by metastatic colorectal cancer (mCRC). Its safety profile is typical of small-molecule tyrosine-kinase inhibitors (TKIs) and most adverse events are manageable. PATIENT CONCERNS: A 56 years-old Caucasian ma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Quirino, Michela, Rossi, Sabrina, Schinzari, Giovanni, Basso, Michele, Strippoli, Antonia, Cassano, Alessandra, Barone, Carlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2017
Konular:
5700
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406055/
https://ncbi.nlm.nih.gov/pubmed/28422839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006522
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller